Substrate
Topic

vaccine-development

3 stories related to this topic, newest first.

Moderna Collaborates on Preclinical mRNA Hantavirus Vaccine in South Koreabenzinga.com
world4 hrs agoDeveloping

Moderna Collaborates on Preclinical mRNA Hantavirus Vaccine in South Korea

Newsweek reported that Moderna is involved in early-stage development of an mRNA vaccine targeting hantaviruses causing hemorrhagic fever with renal syndrome. The preclinical project, announced in 2024 by Korea University’s Vaccine Innovation Center, focuses on Asian strains and…

Newsweek
globalresearch.ca
2 sources
Moderna mRNA Flu Vaccine Beats Standard Shot in Phase 3 TrialUsa Today
health6 hrs agoFraming55Framing risk55/100Rewrite largely neutral on trial data but inherits mild valence skew and lede_misdirection by foregrounding regulatory drama and RFK Jr. criticism over the core efficacy result.Click to jump to full framing analysis

Moderna mRNA Flu Vaccine Beats Standard Shot in Phase 3 Trial

Moderna's mRNA-based seasonal flu vaccine proved 26.6 percent more effective than a conventional flu shot in a trial of more than 40,000 adults aged 50 and older. Results from the Phase 3 study were published Wednesday in the New England Journal of Medicine. The vaccine awaits a…

Usa Today
Nbc News
2 sources
Is There a Cure for Hantavirus? Every Treatment on the Table, From Ivermectin to Vaccines.Substrate placeholder — needs review
science8 hrs agoSourced

Is There a Cure for Hantavirus? Every Treatment on the Table, From Ivermectin to Vaccines.

No antiviral or vaccine for hantavirus is approved by the FDA. Some drugs work in vitro but fail in human trials. Ivermectin and hydroxychloroquine — the two most-asked-about repurposed drugs — have zero published research against hantavirus. Here is what every candidate, includi…

Indian Journal of Pharmacology
PubMed
Antiviral Research
10 sources